Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05160233 · ClinicalTrials.gov registry record · NA

Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care

A NA study of Opioid Use Disorder and Alcohol-Related Disorders, sponsored by Kaiser Permanente.

Active
Registry status
NA
Development phase
13,000
Enrollment target
1
Study location

NCT05160233 is a NA study of Opioid Use Disorder and Alcohol-Related Disorders that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 13,000 participants, above the 4,606-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (182% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05160233, a NA study of Opioid Use Disorder and Alcohol-Related Disorders, is active but no longer recruiting, sponsored by Kaiser Permanente.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
13,000 participants
Enrollment target
1
Study location

Study Summary

The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care. The DIGITS Trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, and Kaiser Permanente Washington, a healthcare delivery system in Washington State. In this study, the FDA-authorized reSET and reSET-O digital therapeutics will be implemented in Kaiser Permanente Washington primary care clinics. The study will evaluate the extent to which two implementation strategy interventions, health coaching and practice coaching, improve the implementation. Primary care clinics are randomized to receive these implementation strategy interventions. Each clinic will have a 12-month active implementation period beginning on its date of randomization. To study the continued use of reSET and reSET-O after the active implementation period is completed, a sustainment period of up 12 months will follow the active implementation period.

Interventions

  • BEHAVIORAL Health Coaching
  • BEHAVIORAL Practice Facilitation
  • BEHAVIORAL Standard implementation

Study Locations (1)

Washington

  • Kaiser Permanente Washington - Seattle

Trial Details

FieldValue
Enrollment Target 13,000 participants
Start Date 2021-12-09
Est. Completion 2024-09-09
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT05160233

The ClinicalTrials.gov registry entry for NCT05160233 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 13,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,606-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (182% higher). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Health Coaching is the first listed.

NCT05160233 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT05160233 about?

NCT05160233 is a clinical study titled "Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care". The DIGITS Trial addresses a critical knowledge gap: How to best implement digital treatments for opioids and other substance use disorders in primary care. The DIGITS Trial is a partnership between Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle, and Kaiser Permanente Was...

What is the current status of trial NCT05160233?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 13,000 participants. The study started on 2021-12-09. Estimated completion is 2024-09-09.

What conditions does trial NCT05160233 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Alcohol-Related Disorders, Drug Use Disorders, Illicit Drug Use.

What interventions are being tested in trial NCT05160233?

The interventions under investigation include: Health Coaching (BEHAVIORAL), Practice Facilitation (BEHAVIORAL), Standard implementation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05160233?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05160233 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.